arrow
M

Mariano Barbacid

centro nacional de investigaciones oncológicas
H指数:120
被引数:6.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FAK inhibitor and RAF/MEK clamp avutometinib enhance KRAS G12C inhibitor efficacy in preclinical models of non–small cell lung cancer

FAK抑制剂和RAF/MEK夹具avutometinib增强KRAS G12C抑制剂在非小细胞肺癌预临床模型中的疗效

2026-09-300
PRE
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome

肺癌和卵巢癌对铂类化疗的治疗耐药性是由可靶向的tgf β 衰老分泌蛋白驱动的

2026-02-030
OAAI
T Cell-Specific Inactivation of the PI3K p110α Catalytic Subunit: Effect in T Cell Differentiation and Antigen-Specific Responses

T细胞特异性失活PI3K p110α催化亚基:对T细胞分化和抗原特异性反应的影响

2025-01-120
OA
Type I interferon signaling pathway enhances immune- checkpoint inhibition in KRAS mutant lung tumors

I型干扰素信号通路增强KRAS突变型肺肿瘤的免疫检查点抑制

2024-08-260
PRE
Enabling biomarkers of chromosomal instability for tumor only targeted gene panel sequencing
2024-03-220
PRE
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
2023-10-109
OAAI
A tumor-promoting senescent secretome triggered by platinum chemotherapy exploits a targetable TGFβR1/Akt-mTOR axis in lung cancer
2023-04-040
PRE
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
2023-04-0316
OAAI
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein
2023-02-224
OAAI